FIELD: peptides, pharmacy. SUBSTANCE: invention relates to cyclopeptides of the formula (I): Cyclo-(Arg-Gly-Asp-X-Y) where X means Phe, homo-Phe, Phg, Phe (4-F) or Phe (4-Cl); Y means hPro, Ahds, Aos, Nhdg, Acha, Aib, Acpa or Tle being in the case of residues of optically active amino acids and derivatives of amino acids D- and L-forms also and derivatives, especially β-ester of aspartic acid or N-guanidineacyl-derivatives of arginine, prodrugs and their physiologically acceptable salts. Compounds show high activity as inhibitors of integrin and also an anti-inflammatory effect. Invention describes also a method of synthesis of cyclopeptides and a pharmaceutical composition showing ability to inhibit integrin. EFFECT: valuable properties of cyclopeptides. 6 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS, CONTAINING CYCLIC PEPTIDES AND METHODS OF APPLYING THEREOF | 2009 |
|
RU2555357C2 |
CYCLOPEPTIDES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD OF ITS PREPARING | 1996 |
|
RU2157379C2 |
CYCLOPEPTIDES, A METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEIR AND A METHOD OF THEIR PREPARING | 1994 |
|
RU2130030C1 |
BIOTIN DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF THEIR PREPARING | 1996 |
|
RU2171807C2 |
CYCLOPEPTIDE DERIVATIVES | 1997 |
|
RU2202557C2 |
CYCLIC AZAPEPTIDES WITH ANGIOGENIC EFFECT | 1998 |
|
RU2188205C2 |
CYLLOPEPTIDE DERIVATIVES | 1996 |
|
RU2174520C2 |
CYCLOPEPTIDES OF SALTS THEREOF, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS, METHOD OF PREPARING THEREOF, AND METHOD OF TREATMENT | 1993 |
|
RU2129563C1 |
CYCLOPEPTIDES AND METHOD OF PREPARATION THEREOF | 1995 |
|
RU2151776C1 |
LIQUID PREPARATION CONTAINING OLIGOPEPTIDES AND ESTERIFIED CYCLODEXTRIN | 2003 |
|
RU2322254C2 |
Authors
Dates
2002-06-27—Published
1997-04-02—Filed